Cancer Management and Research
Volume 9, 2017 - Issue
Open access
103
Views
0
CrossRef citations to date
0
Altmetric
Review
Emerging combination therapies for the management of multiple myeloma: the role of elotuzumab
Wei-Chih Chen1 Department of Pharmaceutical Sciences, School of Pharmacy
, Abraham S Kanate2 Osborn Hematopoietic Malignancy and Transplantation Program, West Virginia University;3 West Virginia University Cancer Institute, Morgantown, WV, USA
, Michael Craig2 Osborn Hematopoietic Malignancy and Transplantation Program, West Virginia University;3 West Virginia University Cancer Institute, Morgantown, WV, USA
, William P Petros1 Department of Pharmaceutical Sciences, School of Pharmacy;3 West Virginia University Cancer Institute, Morgantown, WV, USA
& Lori A Hazlehurst1 Department of Pharmaceutical Sciences, School of Pharmacy;2 Osborn Hematopoietic Malignancy and Transplantation Program, West Virginia University;3 West Virginia University Cancer Institute, Morgantown, WV, USACorrespondence[email protected]
Pages 307-314
|
Published online: 12 Jul 2017
Reprints and Permissions
Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.
To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.
For more information please visit our Permissions help page.
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.